申请人:Janssen Pharmaceutica N.V.
公开号:US07897643B2
公开(公告)日:2011-03-01
The present disclosure relates to compounds having the general Formula (I) with the definitions of R1, R2, R3, and R4 as provided herein, and/or salts thereof. The disclosure also relates to the use of such compounds for the treatment of Alzheimer's disease, and for the modulation of γ-secretase activity.
本公开涉及具有一般式(I)的化合物,其中R1,R2,R3和R4的定义如本文所提供,并/或其盐。本公开还涉及使用这些化合物治疗阿尔茨海默病以及调节γ-分泌酶活性。